查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1356799

口咽癌诊断与治疗药物市场报告：2030 年趋势、预测与竞争分析

Oropharyngeal Cancer Diagnosis and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

口咽癌诊疗药物的发展趋势及预测

预计到2030年，全球口咽癌诊断和治疗市场将达33亿美元，2024年至2030年年复合成长率为9.2%。该市场的主要促进因素是口咽癌罹患率上升、烟酒消费量高以及人类乳突病毒（HPV）感染率上升。全球口咽癌诊断和治疗药物市场前景广阔，医院和门诊手术中心市场存在商机。

口咽癌诊断与治疗药物市场洞察

Lucintel 预测 CT 扫描将在预测期内达到最高成长。

医院是最大的部分，因为它们是诊断和治疗口咽癌的主要设施，并拥有提供这些关键服务所需的必要基础设施和专业知识。将会继续。

由于口咽癌患者数量不断增加以及人们对口咽癌的认识不断增强，预计亚太地区在预测期内将出现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球口咽癌诊断与治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球口咽癌诊断及治疗市场趋势（2018-2023）及预测（2024-2030）
  • 按类型分類的全球口咽癌诊断和治疗市场
    • 内视镜
    • 切片检查
    • 影像
    • 核磁共振扫描
    • CT扫描
    • 宠物CT扫描
  • 按治疗分類的全球口咽癌诊断与治疗市场
    • 外科手术
    • 化疗
    • 放射治疗
    • 标靶治疗
    • 其他的
  • 全球口咽癌诊断与治疗市场（依最终用途）
    • 医院
    • 门诊手术中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球口咽癌诊断与治疗市场（按地区）
  • 北美口咽癌诊断与治疗市场
  • 欧洲口咽癌诊断与治疗市场
  • 亚太地区口咽癌诊断与治疗市场
  • 其他地区口咽癌诊疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球口咽癌诊断与治疗市场成长机会（按类型）
    • 全球口咽癌诊断与治疗市场的治疗成长机会
    • 全球口咽癌诊断和治疗市场成长机会（按最终用途）
    • 全球口咽癌诊断与治疗市场按地区成长机会
  • 全球口咽癌诊断与治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球口咽癌诊断和治疗市场的能力
    • 全球口咽癌诊断和治疗市场的收购和合资
    • 认证和许可

第7章主要企业概况

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck
简介目录

Oropharyngeal Cancer Diagnosis and Therapeutics Trends and Forecast

The future of the global oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption ,and rise in human papillomavirus (hpv) infections.

A more than 150-page report is developed to help in your business decisions.

Oropharyngeal Cancer Diagnosis and Therapeutics by Segment

The study includes a forecast for the global oropharyngeal cancer diagnosis and therapeutics by type, treatment, end use, and region.

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Endoscopy
  • Biopsy
  • Imaging
  • MRI Scan
  • CT Scan
  • Pet-CT Scan

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oropharyngeal Cancer Diagnosis and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oropharyngeal cancer diagnosis and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oropharyngeal cancer diagnosis and therapeutics companies profiled in this report include-

  • Ab Sciences
  • Advaxis
  • Astrazeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • Ge Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Oropharyngeal Cancer Diagnosis and Therapeutics Market Insights

Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Hospitals will remain the largest segment as it serves as the primary facilities for diagnosing and treating oropharyngeal cancer and possess the essential infrastructure and specialized expertise required to deliver these crucial services.

APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Features of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market

Market Size Estimates: Oropharyngeal cancer diagnosis and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Oropharyngeal cancer diagnosis and therapeutics market size by type, treatment, end use, and region. in terms of value ($B).

Regional Analysis: Oropharyngeal cancer diagnosis and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatments , end uses, and region.s for the oropharyngeal cancer diagnosis and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oropharyngeal cancer diagnosis and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the oropharyngeal cancer diagnosis and therapeutics market size?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030.

Q.2. What is the growth forecast for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to grow with a CAGR of 9.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the oropharyngeal cancer diagnosis and therapeutics market?

Answer: The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption, and rise in human papillomavirus (HPV) infections.

Q.4. What are the major segments for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The future of the oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q.5. Who are the key oropharyngeal cancer diagnosis and therapeutics market companies?

Answer: Some of the key oropharyngeal cancer diagnosis and therapeutics companies are as follows:

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Q.6. Which oropharyngeal cancer diagnosis and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Q.7. In oropharyngeal cancer diagnosis and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oropharyngeal cancer diagnosis and therapeutics market by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), end use (hospitals, ambulatory surgery centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 3.3.1: Endoscopy
    • 3.3.2: Biopsy
    • 3.3.3: Imaging
    • 3.3.4: MRI Scan
    • 3.3.5: CT Scan
    • 3.3.6: Pet-CT Scan
  • 3.4: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 3.4.1: Surgery
    • 3.4.2: Chemotherapy
    • 3.4.3: Radiation Therapy
    • 3.4.4: Targeted Therapy
    • 3.4.5: Others
  • 3.5: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgery Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 4.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.2.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.3: European Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.3.1: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.3.2: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.4.1: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.4.2: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.5.1: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.5.2: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ab Sciences
  • 7.2: Advaxis
  • 7.3: AstraZeneca
  • 7.4: Bayer
  • 7.5: Boston Biomedical
  • 7.6: Bristol-Myers Squibb
  • 7.7: GE Healthcare
  • 7.8: Immunovaccine
  • 7.9: Inovio Pharmaceuticals
  • 7.10: Merck